Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Drug save search
Kiora Pharmaceuticals Receives Investigational New Drug Approval for Phase 2 Study of KIO-101 for Treatment of Ocular Presentation of Autoimmune Diseases
Published: 2023-02-07 (Crawled : 15:00) - biospace.com/
KPRX | $6.12 34.51% 14M
|
Manufacturing
|
| O: 64.94%
H: 0.0%
C: 0.0%
kio-101 treatment pharmaceuticals drug for ocular approval presentation study
FSD Pharma Receives Regulatory Clearance for Its Proposed Phase-1 Clinical Trial of Lucid-21-302 (Lucid-MS), First-in-Class Multiple Sclerosis Drug Candidate
Published: 2023-02-07 (Crawled : 15:00) - fsdpharma.com
HUGE | $1.32 140K
|
Process Industries
|
| O: 7.38%
H: 0.0%
C: 0.0%
clearance pharma drug candidate for trial sclerosis lucid-ms lucid-21-302
Aldeyra Therapeutics Announces FDA Acceptance of New Drug Application for Reproxalap for the Treatment of Dry Eye Disease
Published: 2023-02-07 (Crawled : 13:00) - biospace.com/
ALDX | $6.84 1.03% 250K
|
Health Technology
|
| O: 8.04%
H: 0.0%
C: 0.0%
treatment fda drug disease for eye application therapeutics reproxalap
Intelligent Bio Solutions Inc. Announces Leading Food Industry Logistics Provider to Implement Fingerprint Drug Testing, Replacing Urine Testing
Published: 2023-02-07 (Crawled : 13:00) - biospace.com/
INBS | $0.7 -3.87% 140K
|
Manufacturing
|
| O: 9.36%
H: 0.0%
C: 0.0%
drug solutions urine food
Sage Therapeutics and Biogen Announce FDA Accepts Filing of New Drug Application and Grants Priority Review of Zuranolone in the Treatment of Major Depressive Disorder and Postpartum Depression
Published: 2023-02-06 (Crawled : 12:20) - biospace.com/
SAGE | $45.7 -1.87% 82K
|
Health Technology
|
| O: -0.19%
H: 6.75%
C: 3.25%
BIIB A | $287.995 -1.18% 230K
|
Health Technology
|
| O: -1.7%
H: 2.52%
C: 1.12%
treatment fda drug application grants therapeutics review depression
Biogen and Sage Therapeutics Announce FDA Accepts Filing of New Drug Application and Grants Priority Review of Zuranolone in the Treatment of Major Depressive Disorder and Postpartum Depression
Published: 2023-02-06 (Crawled : 12:00) - globenewswire.com
SAGE | $45.7 -1.87% 82K
|
Health Technology
|
| O: -0.19%
H: 6.75%
C: 3.25%
BIIB A | $287.995 -1.18% 230K
|
Health Technology
|
| O: -1.7%
H: 2.52%
C: 1.12%
treatment fda drug application grants therapeutics review depression
Pliant Therapeutics Announces FDA Clearance of Investigational New Drug Application for PLN-101095, A Novel Integrin Inhibitor for the Treatment of Solid Tumors
Published: 2023-02-02 (Crawled : 13:20) - globenewswire.com
PLRX M | $31.94 -1.05% 140K
|
Health Technology
|
| O: -0.3%
H: 2.42%
C: -1.93%
pln-1010 treatment fda clearance drug for therapeutics tumors
Correcting & Replacing -- Celularity Receives Preliminary Assessment of Product Classification and Jurisdiction for Its Investigational Celularity Tendon Wrap (CTW) to be Regulated as a Device Within U.S. Food and Drug Administration (FDA) Center for Devices and Radiological Health (CDRH)
Published: 2023-02-02 (Crawled : 13:00) - globenewswire.com
CELU | $0.8472 -4.83% 290K
|
|
| O: 6.16%
H: 7.64%
C: 3.95%
drug device for health food
CLINUVEL Drug Significantly Reduces Critical UV Skin Damage in Fair-Skinned Individuals
Published: 2023-02-02 (Crawled : 01:00) - globenewswire.com
CLVLY | $17.0 0
|
Professional, Scientific, and T...
| Email alert
Add to watchlist
CLVLF | $17.25 0
|
Health Technology
| Email alert
Add to watchlist
drug skin
Jaguar Health & SynWorld Technologies Mutually Agree to Terminate License and Commercialization Agreement for Canalevia for Treatment of Diarrhea in Dogs in China Given Jaguar’s 2023 Focus on Human Drug Development
Published: 2023-02-01 (Crawled : 15:00) - jaguarhealth.gcs-web.com
JAGX | $4.26 -5.12% 210K
|
Health Technology
|
| O: 4.43%
H: 1.7%
C: -3.61%
treatment drug diarrhea for health commercialization license agreement china
XORTX Announces Submission of Orphan Drug Designation Request for XRx-008 Program to Treat Autosomal Dominant Kidney Disease
Published: 2023-02-01 (Crawled : 12:00) - xortx.com
XRTX | $0.62 97K
|
Mining, Quarrying, and Oil and ...
|
| O: 12.03%
H: 2.69%
C: -1.54%
designation drug disease for kidney program xrx-008 submission
Global Large Molecule Drug Substance CDMO Market Report 2022: Sector to Reach $19.2 Billion by 2028 at a CAGR of 8.7%
Published: 2023-01-31 (Crawled : 23:00) - prnewswire.com
CTLT | $71.17 -0.57% 1.4M
|
Health Technology
|
| O: 0.9%
H: 1.43%
C: 1.28%
drug global report market
Blockchain Technology in Healthcare Market Report 2023: Drug Discovery and Clinical Trials Set to Present Opportunities
Published: 2023-01-31 (Crawled : 19:00) - prnewswire.com
SNY | $47.62 1.38% 1M
|
Health Technology
|
| O: -0.51%
H: 0.0%
C: 0.0%
trials drug report blockchain set technology market
Fennec Pharmaceuticals Announces PEDMARK® (sodium thiosulfate injection) Receives Orphan Drug Exclusivity from U.S. FDA
Published: 2023-01-31 (Crawled : 13:20) - biospace.com/
FENC | $9.89 -0.8% 4.9K
|
Health Technology
|
| O: 1.62%
H: 8.3%
C: 6.49%
pedmark fda pharmaceuticals drug
Insights on the Local Anesthesia Drugs Global Market to 2027 - by Drug Type, Mode of Administration, Distribution Channel and Region
Published: 2023-01-28 (Crawled : 12:20) - prnewswire.com
ENDPQ | $0.0925 0
|
n/a
| Email alert
Add to watchlist
ENDP | $0.2926 -9.6%
|
Health Technology
| Email alert
Add to watchlist
BAX | $45.68 0.15% 1.7M
|
Health Technology
| Email alert
Add to watchlist
drug global distribution market
London-listed SPAC targets merger with chronic disease drug developer Istesso – Yahoo Eurosport UK
Published: 2023-01-28 (Crawled : 12:20) - spacfeed.com
EXPR | $1.265 -4.89% 1.4M
|
Retail Trade
| Email alert
Add to watchlist
drug disease spac
London-listed SPAC targets merger with chronic disease drug developer Istesso – Sky News
Published: 2023-01-28 (Crawled : 12:20) - spacfeed.com
EXPR | $1.265 -4.89% 1.4M
|
Retail Trade
| Email alert
Add to watchlist
drug disease spac
Salarius Pharmaceuticals Presents SP-3164 Preclinical Data at the Inaugural Molecular Glue Drug Development Summit
Published: 2023-01-27 (Crawled : 20:00) - biospace.com/
SLRX | $2.12 -9.4% 18K
|
Commercial Services
|
| O: 4.69%
H: 0.0%
C: 0.0%
sp-3164 pharmaceuticals drug preclinical molecular
Sana Biotechnology Announces FDA Clearance of Investigational New Drug Application for SC291, a Hypoimmune-modified, CD19-targeted Allogeneic CAR T Therapy for Patients with B-Cell Malignancies
Published: 2023-01-26 (Crawled : 23:00) - biospace.com/
SANA | $4.51 -5.25% 170K
|
|
| O: 1.06%
H: 1.05%
C: -3.15%
sc291 fda clearance drug for application therapy
Tonix Pharmaceuticals Announces Presentation of Licensed Antiviral Drug Technology at the 2nd Wnt & β-catenin Targeted Drug Development Conference
Published: 2023-01-26 (Crawled : 22:00) - globenewswire.com
TNXP | $1.24 5.09% 3.2M
|
Health Technology
|
| O: -2.17%
H: 0.0%
C: 0.0%
pharmaceuticals drug conference antiviral technology presentation
Gainers vs Losers
| 52% | 48% |
Top 10 Gainers
DGLY | $5.43 1722.15% 160K
|
Electronic Technology
CELZ | $1.07 106.84% 120M
|
AVRO | $1.48 69.63% 7M
|
Health Technology
GFAI | $0.4765 39.53% 61M
|
KPRX | $6.12 34.51% 14M
|
Manufacturing
PRFX | $0.65 30.0% 13M
|
Health Technology
WETG | $0.5211 27.1% 11M
|
BBLG | $0.3799 20.76% 740K
|
n/a
MSGM P | $15.74 19.42% 5.2M
|
NEWR A | $76.93 19.12% 2.6M
|
Technology Services
Your saved searches
Save your searches and get alerts when important news are released.